Abbreviations
- DEX:
-
dexmedetomidine
- LEV:
-
levomedetomidine
- MED:
-
metedomidine
References
Aho M., Scheinin M., Lehtinen A.M., Erkola O., Vuorinen J., Korttila K., 1992. Intramuscularly administered dexmedetomidine attenuates hemodynamic and stress hormone responses to gynecologic laparoscopy. Anesthesia and Analgesia, 6, 932–939.
Ansah O.B., Raekallio M., Vainio O., 1998. Comparison of three doses of dexmedetomidine with medetomidine in cats following intramuscular administration. Journal of Veterinary Pharmacology and Therapeutics, 5, 380–387.
Ansah O.B., Raekallio M., Vainio O., 2000. Correlation between serum concentrations following continuous intravenous infusion of dexmedetomidine or medetomidine in cats and their sedative and analgesic effects. Journal of Veterinary Pharmacology and Therapeutics, 1, 1–8.
Cullen L.K., 1996. Medetomidine sedation in dogs and cats: a review of its pharmacology, antagonism and dose. British Veterinary Journal, 5, 519–535.
Doze V.A., Chen B.X., Li Z., Maze M., 1989. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine. Acta Veterinaria Scandinavica, 85, 61–64.
Granholm M., McKusick B.C., Westerholm F.C., Aspegrén J.C., 2006. Evaluation of the clinical efficacy and safety of dexmedetomidine or medetomidine in cats and their reversal with atipamezole. Veterinary Anaesthesia and Analgesia, 4, 214–223.
Granholm M., McKusick B.C., Westerholm F.C., Aspegrén J.C., 2007. Evaluation of the clinical efficacy and safety of intramuscular and intravenous doses of dexmedetomidine and medetomidine in dogs and their reversal with atipamezole. Veterinary Record, 26, 891–897.
Kuusela E., Raekallio M., Anttila M., Falck I., Mölsä S., Vainio O., 2000. Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs. Journal of Veterinary Pharmacology and Therapeutics, 1, 15–20.
Kuusela E., Vainio O., Kaistinen A., Kobylin S., Raekallio M., 2001. Sedative, analgesic, and cardiovascular effects of levomedetomidine alone and in combination with dexmedetomidine in dogs. American Journal of Veterinary Research, 4, 616–621.
MacDonald E., Scheinin M., Scheinin H., Virtanen R., 1991. Comparison of the behavioral and neurochemical effects of the two optical enantiomers of medetomidine, a selective alpha2-adrenoceptor agonist. The Journal of Pharmacology and Experimental Therapeutics, 2, 848–854.
Mendes G.M., Selmi A.L., Barbudo-Selmi G.R., Lins B.T., Figueiredo J.P., 2003. Clinical use of dexmedetomidine as premedicant in cats undergoing propofol-sevoflurane anaesthesia. Journal of Feline Medicine and Surgery, 5, 265–270.
Savola J.M. and Virtanen R., 1991. Central alpha2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine. European Journal of Pharmacology, 2, 193–199.
Schwinn D.A., Correa-Sales C., Page S.O., Maze M., 1991. Functional effects of activation of alpha1-adrenoceptors by dexmedetomidine: in vivo and in vitro studies. The Journal of Pharmacology and Experimental Therapeutics, 3, 1147–1152.
Stenberg D., Salvén P., Miettinen M.V., 1987. Sedative action of the alpha2-agonist medetomidine in cats. Journal of Veterinary Pharmacology and Therapeutics, 4, 319–323.
Vähä-Vahe T., 1989. Clinical evaluation of medetomidine, a novel sedative and analgesic drug for dogs and cats. Acta Veterinaria Scandinavica, 3, 267–273.
Virtanen R., Savola J.M., Saano V., Nyman L., 1988. Characterization of the selectivity, specificity and potency of medetomidine as an alpha2-adrenoceptor agonist. European Journal of Pharmacology, 1–2, 9–14.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scrollavezza, P., Tambella, A.M., Vullo, C. et al. Evaluation of the muscular relaxant effect of dexmedetomidine or medetomidine in cats. Vet Res Commun 33 (Suppl 1), 213–215 (2009). https://doi.org/10.1007/s11259-009-9271-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11259-009-9271-y